인공 각막 및 각막 임플란트 시장 규모, 점유율, 성장 분석 : 유형별, 이식 유형별, 질환 적응증별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Artificial Cornea and Corneal Implant Market size was valued at USD 487.81 Million in 2024 and is poised to grow from USD 523.91 Million in 2025 to USD 927.45 Million by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

Market insights reveal that the rising incidence of ophthalmic diseases, combined with consumers' increased willingness to invest in eye care, is expected to enhance demand for artificial corneas and corneal implants. Additionally, heightened awareness about eye donation and a growing number of organ donors are contributing factors to the expansion of this market. The growing accessibility of reliable eye transplant procedures and improvements in reimbursement for these procedures further support the anticipated sales growth of artificial corneas and corneal implants. Nonetheless, high costs in certain regions may impede market development. Furthermore, the rapidly increasing geriatric population globally is likely to drive sustained demand for artificial corneas and corneal implants, positioning them as critical components in the evolving eye care landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Cornea and Corneal Implant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Cornea and Corneal Implant Market Segments Analysis

Global Artificial Cornea and Corneal Implant Market is segmented by Type, Transplant Type, Disease Indication, End User and region. Based on Type, the market is segmented into Human Cornea and Artificial Cornea. Based on Transplant Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior lamellar keratoplasty and keratoprosthesis. Based on Disease Indication, the market is segmented into Fuchs' Dystrophy, Fungal Keratitis, Keratoconus and Others. Based on End User, the market is segmented into Hospitals & Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Cornea and Corneal Implant Market

The rising global aging population, coupled with heightened exposure to screens, has significantly contributed to the prevalence of corneal disorders. This surge in eye-related issues is driving an increasing demand for corneal transplantation as a treatment option. As a result, the need for artificial corneas and corneal implants is expected to grow, reflecting the urgent requirement for innovative solutions in eye care. With more individuals facing corneal health challenges, the market for artificial corneas and implants stands to benefit, showcasing a critical response to the health needs of an evolving demographic landscape.

Restraints in the Global Artificial Cornea and Corneal Implant Market

The Global Artificial Cornea and Corneal Implant market faces challenges due to limited coverage and reimbursement for corneal transplantation procedures by various healthcare insurance plans. As a result, many individuals must finance these services out of their own pockets. The high costs associated with these procedures contribute to patients' reluctance to invest significant amounts of money, which may hinder the overall growth and expansion of the market. Consequently, the financial burden placed on patients can act as a significant restraint, limiting access to essential treatments and impeding the advancement of innovative corneal solutions.

Market Trends of the Global Artificial Cornea and Corneal Implant Market

The global market for artificial corneas and corneal implants is witnessing a significant trend towards the adoption of minimally invasive surgical techniques. As patient preferences shift towards these less invasive options, manufacturers are encouraged to enhance the accessibility and efficacy of their products tailored for such procedures. Concurrently, a focus on securing favorable reimbursement frameworks for these advanced treatments is expected to further stimulate demand and expansion within the market. This evolving landscape not only highlights the importance of innovative solutions but also underscores the necessity for market players to adapt to evolving consumer expectations in ocular health.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Artificial Cornea and Corneal Implant Market Size by Type & CAGR (2026-2033)

• Market Overview
• Human Cornea
• Artificial Cornea

Global Artificial Cornea and Corneal Implant Market Size by Transplant Type & CAGR (2026-2033)

• Market Overview
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Anterior lamellar keratoplasty
• keratoprosthesis

Global Artificial Cornea and Corneal Implant Market Size by Disease Indication & CAGR (2026-2033)

• Market Overview
• Fuchs' Dystrophy
• Fungal Keratitis
• Keratoconus
• Others

Global Artificial Cornea and Corneal Implant Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Ambulatory Surgical Centers
• Specialty Clinics

Global Artificial Cornea and Corneal Implant Market Size & CAGR (2026-2033)

• North America (Type, Transplant Type, Disease Indication, End User)
  • US
  • Canada
• Europe (Type, Transplant Type, Disease Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Transplant Type, Disease Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Transplant Type, Disease Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Transplant Type, Disease Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CorNeat Vision (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KeraMed, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LinkoCare Life Sciences AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIOPTEX GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EyeYon Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJL Ophthalmic SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorneaGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Florida Lions Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• San Diego Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alabama Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Massachusetts Eye and Ear (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advancing Sight Network (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• L V Prasad Eye Institute (LVPEI, India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Inc. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurolab (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cornea Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Price Vision Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations